More information is available here: https://istanbulnbiasymposium.com/
The 8th International Symposium on Neurodegeneration with Brain Iron Accumulation & Related Disorders will take place between October 13th and 15th in Lausanne, Switzerland. More information is available here:
https://nbiasuisse.org/8th-international-symposium-on-nbia/
February 22, 2021 The article about Treat Iron-Related Childhood-Onset Neurodegeneration (TIRCON) is now officially published and is availalbe under this link https://doi.org/10.3389/fneur.2021.642228
For further information, please read the press release. The statement of the principle investigator Prof. Thomas Klopstock's (in German) can be found here.
...have been published in Lancet Neurology, the publication abstract is available here.
The 6th International Symposium on Neurodegeneration with Brain Iron Accumulation & Related Disorders took place on April 7th and 8th in Stevenson, Washington, USA. For more information, please visit http://bit.ly/NBIASymposium.
The European Medicines Agency (EMA) has granted orphan drug designation to a new candidate compound CAB1803 for the treatment of PKAN, developed by TIRCON partners Acies Bio and University Medical Centre Groningen. For further information, please read the press release.
The Clinical trial of Deferiprone in PKAN is now fully randomized.
TIRCON partners UMCG and Acies Bio developed a new candidate compound for the treatment of PKAN. For further information, please read the press release.